Our novel, safe viral vector platform enables the fast generation of mono- or multivalent vaccines against infectious diseases and cancer. The application results in strong balanced B-/T-cell immune response without any adjuvant and without the necessity of vector virus multiplication. Multiple or prime-boost immunizations can be easily performed.
Biotechnology
Tübingen, Baden-Württemberg
Founded in 2019
1-10 employees
Our novel, safe viral vector platform enables the fast generation of mono- or multivalent vaccines against infectious diseases and cancer. The application results in strong balanced B-/T-cell immune response without any adjuvant and without the necessity of vector virus multiplication. Multiple or prime-boost immunizations can be easily performed.
Company Information
- Industry
- Biotechnology
- Company Type
- Public Company
- Founded
- 2019
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- City
- Tübingen
- Region
- Baden-Württemberg
- Postal Code
- 72070
- Country
- Germany
Web Presence
LinkedIn0 followers
